In patients with subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y in those with previous stroke or TIA. Alberts MJ. Ann Intern Med 2025 May 6. doi: 10.7326/ANNALS-25-01330.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alberts MJ. In patients with subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at 3.5 y in those with previous stroke or TIA. Ann Intern Med 2025 May 6. doi: 10.7326/ANNALS-25-01330.
PMID: 40324194